Tag: Sputnik V

Wockhardt to produce, supply Sputnik V and Sputnik Light vaccines in India

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Wockhardt Limited, a global pharmaceutical company headquartered in India, have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19. The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF’s coordination partner for sourcing Sputnik V…

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Stelis Biopharma Pvt. Ltd., the biopharmaceutical division of Strides, a global pharmaceutical company headquartered in India, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 million people. The agreement…

Dr. Reddy’s join hands with BIRAC for Sputnik V vaccine clinical trials in India

Dr. Reddy’s Laboratories announced its partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support on clinical trials of Sputnik V vaccine in India.  The partnership will allow Dr. Reddy’s to identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under…

Dr. Reddy’s to conduct phase 2/3 human clinical trial for Sputnik V vaccine in India

Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announced that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India. This will be a multicenter and randomized controlled study, which will include…

RDIF and Dr Reddy’s partner to conduct clinical trials and supply 100 mn doses of Sputnik V vaccine to India

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd, a global pharmaceutical company headquartered out of India, announced that they have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.  Upon regulatory approval in India, RDIF shall supply to Dr. Reddy’s 100 million doses…